LUTETIUM-177 PSMA Radioligand
LUPSA
Radboud UMC; Johns Hopkins (investigators) · Phase 2 · Completed · Enrollment 12
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
LUTETIUM-177 PSMA Radioligand
Radboud UMC; Johns Hopkins (investigators) · Phase 2 · Completed · Enrollment 12
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.